Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:STDY

SteadyMed (STDY) Stock Price, News & Analysis

About SteadyMed Stock (NASDAQ:STDY)

Advanced Chart

Key Stats

Today's Range
$4.73
$4.73
50-Day Range
N/A
52-Week Range
$2.60
$6.45
Volume
160 shs
Average Volume
85,138 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive STDY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SteadyMed and its competitors with MarketBeat's FREE daily newsletter.

STDY Stock News Headlines

Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.
Cost of Owning a Dog in Every State (2023 Study)
See More Headlines

STDY Stock Analysis - Frequently Asked Questions

SteadyMed Ltd. (NASDAQ:STDY) announced its quarterly earnings data on Tuesday, August, 14th. The company reported ($0.38) earnings per share for the quarter, missing analysts' consensus estimates of ($0.21) by $0.17.

SteadyMed (STDY) raised $56 million in an IPO on Friday, March 20th 2015. The company issued 4,300,000 shares at a price of $12.00-$14.00 per share. Wells Fargo Securities and RBC Capital Markets acted as the underwriters for the IPO and JMP Securities was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that SteadyMed investors own include Amicus Therapeutics (FOLD), Protalix BioTherapeutics (PLX), Fate Therapeutics (FATE), Madrigal Pharmaceuticals (MDGL), Neurocrine Biosciences (NBIX), Rigel Pharmaceuticals (RIGL) and Sophiris Bio (SPHS).

Company Calendar

Last Earnings
8/14/2018
Today
7/15/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:STDY
CIK
1619087
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:STDY) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners